Home › Funds › GMT CAPITAL CORP › JAZZ
GMT CAPITAL CORP position in JAZZ
JAZZ PHARMACEUTICALS PLC · Health Care
GMT CAPITAL CORP reported holding 412,800 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$95.6M, representing 4.58% of its reported portfolio and ranking #4 among its reported holdings. GMT CAPITAL CORP has disclosed JAZZ holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GMT CAPITAL CORP's JAZZ position evolved
GMT CAPITAL CORP first disclosed a stake in JAZZ in Q3 2024 at 212,000 shares (US$23.6M). The position peaked in Q1 2026 at 581,000 shares, worth US$109.8M. Across 9 filings, GMT CAPITAL CORP increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 412,800 shares valued at US$95.6M — a reduction of -40,700 shares quarter over quarter.. Notable position changes include a 140% increase in Q4 2024 (shares were roughly flat over the following quarter), a 32% increase in Q1 2025 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 212.00K | $23.62M | New |
| Q4 2024 | 508.80K | $62.66M | Add |
| Q1 2025 | 672.90K | $83.54M | Add |
| Q2 2025 | 768.40K | $81.54M | Add |
| Q3 2025 | 792.80K | $104.49M | Add |
| Q4 2025 | 638.50K | $108.55M | Reduce |
| Q1 2026 | 581.00K | $109.84M | Reduce |
| Q2 2026 | 453.50K | $109.28M | Reduce |
| Q3 2026 | 412.80K | $95.57M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 40 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$323.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), Boston Trust Walden Corp (US$98.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.40M sh · $323.77M · Q3 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- Boston Trust Walden Corp 424.57K sh · $98.30M · Q3 2026
- Sofinnova Investments, Inc. 422.38K sh · $97.79M · Q3 2026
More on GMT CAPITAL CORP
FAQ
How long has GMT CAPITAL CORP held JAZZ?
GMT CAPITAL CORP has disclosed JAZZ holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is GMT CAPITAL CORP's current position in JAZZ?
As of Q3 2026, GMT CAPITAL CORP holds 412.80K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $95.57M, representing 4.58% of its reported portfolio and ranking #4.
Has GMT CAPITAL CORP been buying or selling JAZZ?
In the latest 13F filing (Q3 2026), GMT CAPITAL CORP reduced its position in JAZZ. The position peaked in Q1 2026 at 581.00K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, Boston Trust Walden Corp, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.